Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide in Real-World Conditions in Obesity and Type 2 Diabetes in Paraguay
NCT07588438Phase 4Recruiting
- Sponsor
- Las Rías Medical Center
- Start
- Jul 2026
- Primary completion
- Aug 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in obesity, type 2 diabetes mellitus (T2DM), sponsored by Las Rías Medical Center. Started Jul 2026; status: recruiting.
02
Drugs
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07588438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07588438.